We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New Version of Endotoxin Kit Introduced

By LabMedica International staff writers
Posted on 01 Apr 2014
An easy-to-use Limulus Amebocyte Lysate (LAL) gel-clot test enables rapid testing in the laboratory and does not require special laboratory supplies. The easy to follow, step-by-step illustrated instructions allow the user to set up assays within minutes.

The rapid endotoxin detection kit, Pyrosate, was introduced by Associates of Cape Cod, Inc. (ACC; Falmouth, MA, USA) and is licensed by the American Food and Drug Administration (FDA; Silver Spring, MD, USA).

The Pyrosate Kit is now available in sensitivities of 0.03 EU/mL, 0.125 EU/mL and 0.25 EU/mL, in both 10 pack and 30 pack formats. With the introduction of this licensed version, in addition to research and water testing, Pyrosate is ideal for dialysis centers, compounding pharmacies, pharmaceutical, and medical device companies.

Dr. A.J. Meuse, president and CEO of ACC, said, "ACC is the pioneer in endotoxin detection and the first company licensed by the FDA to manufacture LAL for use as a quality control test. We are constantly looking at new approaches to improve existing product offerings and introduce innovative new products. We are quite proud to introduce the newly FDA-licensed Pyrosate Kit."

Related Links:

Associates of Cape Cod, Inc.
American Food and Drug Administration



Gold Member
STI Test
Vivalytic MG, MH, UP/UU
Online QC Software
Acusera 24•7
New
Manual Pipetting Aid
Pipette Controllers macro
New
Automated Clinical Chemistry Analyzer
Envoy 500+

Latest Technology News

Point-of-Care Testing Enhances Health Literacy and Self-Management in Chronic Disease
01 Apr 2014  |   Technology

Fully Automated Sample-to-Insight Workflow Advances Latent TB Testing
01 Apr 2014  |   Technology

Tumor-on-a-Chip Platform Models Pancreatic Cancer Treatment Response
01 Apr 2014  |   Technology



ADLM